scholarly journals Breast Milk Supply of MicroRNA Associated with Leptin and Adiponectin Is Affected by Maternal Overweight/Obesity and Influences Infancy BMI

Nutrients ◽  
2019 ◽  
Vol 11 (11) ◽  
pp. 2589 ◽  
Author(s):  
Rocío Zamanillo ◽  
Juana Sánchez ◽  
Francisca Serra ◽  
Andreu Palou
Keyword(s):  
Breast Milk ◽  
Target Genes ◽  
Maternal Obesity ◽  
Infant Growth ◽  
Normal Weight ◽  
Milk Supply ◽  
Milk Samples ◽  
Lactating Mothers ◽  
Maternal Overweight ◽  
Over Time

Breast milk constitutes a dietary source of leptin, adiponectin and microRNAs (miRNAs) for newborns. Expression of miRNAs previously associated with maternal obesity, leptin or adiponectin function were assessed and their impact on infant weight analyzed. Milk samples were collected (at month 1, 2, and 3) from a cohort of 59 healthy lactating mothers (38 normal-weight and 21 overweight/obese (BMI ≥ 25)), and infant growth was followed up to 2 years of age. Thirteen miRNAs, leptin and adiponectin were determined in milk. Leptin, adiponectin and miRNA showed a decrease over time of lactation in normal-weight mothers that was altered in overweight/obesity. Furthermore, negative correlations were observed in normal-weight mothers between the expression of miRNAs in milk and the concentration of leptin or adiponectin, but were absent in overweight/obesity. Moreover, miRNAs negatively correlated with infant BMI only in normal-weight mothers (miR-103, miR-17, miR-181a, miR-222, miR-let7c and miR-146b). Interestingly, target genes of milk miRNAs differently regulated in overweight/obesity could be related to neurodevelopmental processes. In conclusion, a set of miRNAs present in breast milk, in close conjunction with leptin and adiponectin, are natural bioactive compounds with the potential to modulate infant growth and brain development, an interplay that is disturbed in the case of maternal overweight/obesity.

scholarly journals The Effect of Maternal Obesity on Breast Milk Fatty Acids and Its Association with Infant Growth and Cognition—The PREOBE Follow-Up

Nutrients ◽  
2019 ◽  
Vol 11 (9) ◽  
pp. 2154 ◽  
Author(s):  
Andrea de la Garza Puentes ◽  
Adrià Martí Alemany ◽  
Aida Maribel Chisaguano ◽  
Rosa Montes Goyanes ◽  
Ana I. Castellote ◽  
...  
Keyword(s):  
Fatty Acids ◽  
Breast Milk ◽  
Maternal Obesity ◽  
Infant Growth ◽  
Normal Weight ◽  
Healthy Weight ◽  
Infant Cognition ◽  
Maternal Weight ◽  
Mature Milk ◽  
Milk Fatty Acids

This study analyzed how maternal obesity affected fatty acids (FAs) in breast milk and their association with infant growth and cognition to raise awareness about the programming effect of maternal health and to promote a healthy prenatal weight. Mother–child pairs (n = 78) were grouped per maternal pre-pregnancy body mass index (BMI): normal-weight (BMI = 18.5–24.99), overweight (BMI = 25–29.99) and obese (BMI > 30). Colostrum and mature milk FAs were determined. Infant anthropometry at 6, 18 and 36 months of age and cognition at 18 were analyzed. Mature milk exhibited lower arachidonic acid (AA) and docosahexaenoic acid (DHA), among others, than colostrum. Breast milk of non-normal weight mothers presented increased saturated FAs and n6:n3 ratio and decreased α-linolenic acid (ALA), DHA and monounsaturated FAs. Infant BMI-for-age at 6 months of age was inversely associated with colostrum n6 (e.g., AA) and n3 (e.g., DHA) FAs and positively associated with n6:n3 ratio. Depending on the maternal weight, infant cognition was positively influenced by breast milk linoleic acid, n6 PUFAs, ALA, DHA and n3 LC-PUFAs, and negatively affected by n6:n3 ratio. In conclusion, this study shows that maternal pre-pregnancy BMI can influence breast milk FAs and infant growth and cognition, endorsing the importance of a healthy weight in future generations.

scholarly journals Human Milk Oligosaccharide Concentrations and Infant Intakes Are Associated with Maternal Overweight and Obesity and Predict Infant Growth

Nutrients ◽  
2021 ◽  
Vol 13 (2) ◽  
pp. 446
Author(s):  
Jessica L. Saben ◽  
Clark R. Sims ◽  
Ann Abraham ◽  
Lars Bode ◽  
Aline Andres
Keyword(s):  
Human Milk ◽  
High Performance ◽  
Maternal Obesity ◽  
Critical Role ◽  
Infant Growth ◽  
Normal Weight ◽  
Overweight And Obesity ◽  
Bioactive Molecules ◽  
Maternal Overweight ◽  
Maternal Bmi

Human milk oligosaccharides (HMOs) are bioactive molecules playing a critical role in infant health. We aimed to quantify the composition of HMOs of women with normal weight (18.5–24.9 kg/m2), overweight (25.0–29.9 kg/m2), or obesity (30.0–60.0 kg/m2) and determine the effect of HMO intake on infant growth. Human milk (HM) samples collected at 2 months (2 M; n = 194) postpartum were analyzed for HMO concentrations via high-performance liquid chromatography. Infant HM intake, anthropometrics and body composition were assessed at 2 M and 6 M postpartum. Linear regressions and linear mixed-effects models were conducted examining the relationships between maternal BMI and HMO composition and HMO intake and infant growth over the first 6 M, respectively. Maternal obesity was associated with lower concentrations of several fucosylated and sialylated HMOs and infants born to women with obesity had lower intakes of these HMOs. Maternal BMI was positively associated with lacto-N-neotetraose, 3-fucosyllactose, 3-sialyllactose and 6-sialyllactose and negatively associated with disialyllacto-N-tetraose, disialyllacto-N-hexaose, fucodisialyllacto-N-hexaose and total acidic HMOs concentrations at 2 M. Infant intakes of 3-fucosyllactose, 3-sialyllactose, 6-sialyllactose, disialyllacto-N-tetraose, disialyllacto-N-hexaose, and total acidic HMOs were positively associated with infant growth over the first 6 M of life. Maternal obesity is associated with changes in HMO concentrations that are associated with infant adiposity.

scholarly journals Menaquinone-4 in breast milk is derived from dietary phylloquinone

2002 ◽  
Vol 87 (3) ◽  
pp. 219-226 ◽  
Author(s):  
H. H. W. Thijssen ◽  
M.-J. Drittij ◽  
C. Vermeer ◽  
E. Schoffelen
Keyword(s):  
Vitamin E ◽  
Breast Milk ◽  
Vitamin K ◽  
Post Partum ◽  
Dose Effect ◽  
Plasma Vitamin ◽  
Dependent Manner ◽  
Plasma Samples ◽  
Milk Samples ◽  
Lactating Mothers

The effect of maternal phylloquinone supplementation on vitamin K in breast milk was studied to establish: (1) if phylloquinone is the source of menaquinone-4 in breast milk; (2) the dose–effect relationship between intake and obtainable levels. Four groups of lactating mothers with a full-term healthy infant participated and took oral phylloquinone supplements of 0·0 (n8), 0·8 (n8), 2·0 (n8), and 4·0 (n7) mg/d for 12 d, starting at day 4 post-partum. Milk samples were collected on days 4, 8, 16, and 19. Blood samples were collected on days 4 and 16. Vitamin K and vitamin E concentrations, the latter for reason of comparison, were assayed. Phylloquinone and menaquinone-4 were present in all milk samples: 5·84 (SD 2·31) AND 2·98 (sd 1·51) nmol/l (n31) respectively, in colostrum (day 4 sample). A strong correlation between the vitamers was found (r0·78,P<0·001). Breast-milk phylloquinone levels were raised in a dose-dependent manner: 4-, 12-, and 30-fold on day 16 for the 0·8, 2·0, and 4·0 mg group respectively. In addition, menaquinone-4 levels were higher: 2·5- (P<0·05) and 7-fold (P<0·001) in the 2·0 and 4·0 mg groups respectively. Plasma of supplemented subjects contained 3-, 5-, and 10-fold higher phylloquinone levels on day 16. Detectable menaquinone-4 was found in ten of thirty-one day 4 plasma samples. All day 16 plasma samples of the 4 mg supplemented group contained the vitamin. There was no correlation between the K-vitamers in plasma. Vitamin E and phylloquinone appear to differ in their distribution in breast milk, milk:plasma concentration ratios were ≤1 and 3–5 for vitamin E and phylloquinone respectively. The milk:plasma concentration ratio of menaquinone-4 was >10. In conclusion, dietary phylloquinone is a source of menaquinone-4 in breast milk. Phylloquinone supplementation to lactating mothers may be of benefit to the newborn infant, since both phylloquinone and menaquinone-4 are raised by supplementation.

Analysis of Aflatoxin M1 in Breast Milk and Its Association with Nutritional and Socioeconomic Status of Lactating Mothers in Lebanon

2017 ◽  
Vol 80 (10) ◽  
pp. 1737-1741 ◽  
Author(s):  
Jomana Elaridi ◽  
Maya Bassil ◽  
Joelle Abi Kharma ◽  
Farah Daou ◽  
Hussein F. Hassan
Keyword(s):  
Breast Milk ◽  
Dietary Habits ◽  
Daily Intake ◽  
World Health ◽  
Aflatoxin M1 ◽  
Enzyme Linked Immunosorbent Assay ◽  
Daily Consumption ◽  
Milk Samples ◽  
Lactating Mothers ◽  
The Mean

ABSTRACT Aflatoxin B1 (AFB1) is the most potent of the dietary aflatoxins, and its major metabolite, aflatoxin M1 (AFM1), is frequently found in the breast milk of lactating mothers. The aim of this study was to assess the occurrence and factors associated with AFM1 contamination of breast milk collected from lactating mothers in Lebanon. A total of 111 breast milk samples were collected according to the guidelines set by the World Health Organization. Samples were analyzed with a competitive enzyme-linked immunosorbent assay between December 2015 and November 2016. A survey was used to determine the demographic and anthropometric characteristics of participating lactating mothers. Dietary habits were assessed using a semiquantitative food frequency questionnaire. Mean (±standard deviation) concentration of AFM1 in the breast milk samples was 4.31 ± 1.8 ng/L, and 93.8% of samples contained AFM1 at 0.2 to 7.9 ng/L. The mean concentration of AFM1 was significantly lower (P &lt; 0.05) in fall and winter (4.1 ± 1.9 ng/L) than in spring and summer (5.0 ± 1.7 ng/L). None of the samples exceeded the European Commission regulation limit (25 ng/L) for infant milk replacement formula. AFM1 contamination was significantly associated (P &lt; 0.05) with the daily consumption of white cheeses but not with the consumption of meat or cereal products. No significant association (P &gt; 0.05) was observed between AFM1 concentrations in breast milk and anthropometric sociodemographic factors (age and level of education) or the governorate of residence of the nursing mothers. The mean AFM1 estimated daily intake was found to be 0.69 ng/day/kg of body weight. Although the incidence of AFM1 contamination was low, our first-of-its-kind study highlights the importance of conducting investigations on mycotoxin contamination in breast milk and of developing protection strategies to tackle the exposure of infants to this potent chemical hazard.

scholarly journals Fluoride Levels of Human Plasma and Breast Milk

2007 ◽  
Vol 01 (01) ◽  
pp. 021-024 ◽  
Author(s):  
Yağmur Şener ◽  
Gül Tosun ◽  
Firdevs Kahvecioğlu ◽  
Alparslan Gökalp ◽  
Hasan Koç
Keyword(s):  
Breast Milk ◽  
Fluoride Concentration ◽  
Hospital Setting ◽  
Significant Relation ◽  
Blood Samples ◽  
Milk Samples ◽  
Lactating Mothers ◽  
Primary Selection ◽  
Low Levels ◽  
Fluoride Electrode

ABSTRACTObjectives: The aim of this study was to determine the fluoride levels in breast milk and plasma of lactating mothers who regularly consumed drinking water with low levels of fluoride.Methods: One hundred twenty five healthy mothers aged between 20-30 years old who had given birth within 5-7 days were included in the study. Besides being otherwise healthy, the primary selection criteria stipulated the absence of fluoride supplement consumption one month before delivery. Approximately 5 ml breast milk and 5 ml blood samples were obtained from each participating mother at a hospital setting, where the mothers were scheduled for a regular hospital diet. The blood samples were centrifuged in fluoride-free heparinized polyethylene tubes and stored at -18oC until measurements were made. Breast milk samples were directly refrigerated as with blood samples until measurements. The fluoride concentrations of milk and blood samples were assessed using an ion-selective fluoride electrode combined with an ion analyzer.Results: The fluoride levels of the plasma and breast milk samples were measured as 0.017±0.011 ppm and 0.006±0.002 ppm, respectively. The fluoride concentration of plasma was significantly higher than that of breast milk (P<.01). Correlation analysis revealed a significant relation between the groups (P<.01).Conclusion: A limited level of fluoride transmission from plasma to breast milk was detected. Nevertheless, a significant correlation between the fluoride concentrations of breast milk and plasma was evident. (Eur J Dent 2007;1:21-24)

scholarly journals Maternal Obesity and Risk of Early-onset Neonatal Bacterial Sepsis: Nationwide Cohort and Sibling-controlled Studies

2020 ◽  
Author(s):  
Eduardo Villamor ◽  
Mikael Norman ◽  
Stefan Johansson ◽  
Sven Cnattingius
Keyword(s):  
Early Onset ◽  
Maternal Obesity ◽  
Group B Streptococcus ◽  
Population Based ◽  
Normal Weight ◽  
Overweight And Obesity ◽  
Bacterial Sepsis ◽  
Term Infants ◽  
Cesarean Section Delivery ◽  
Maternal Overweight

Abstract Background Maternal overweight and obesity are related to risks of pregnancy and delivery complications that, in turn, are associated with newborn infections. We examined the associations between early pregnancy body mass index (BMI; kg/m2) and risk of early-onset neonatal bacterial sepsis (EOS). Methods We conducted a nationwide population-based retrospective cohort study of 1 971 346 live singleton infants born in Sweden between 1997 and 2016. Outcome was a culture-confirmed EOS diagnosis. We estimated hazard ratios (HR) of EOS according to BMI using proportional hazard models, and identified potential mediators. Among term infants, we conducted sibling-controlled analyses. Results EOS risk per 1000 live births was 1.48; 0.76 in term and 15.52 in preterm infants. Compared with infants of normal-weight mothers (BMI, 18.5–24.9), the adjusted HR (95% confidence interval [CI]) of EOS for BMI categories &lt;18.5, 25.0–29.9, 30.0–34.9, 35.0–39.9, and ≥40.0 were, respectively, 1.07 (.83–1.40), 1.19 (1.08–1.32), 1.70 (1.49–1.94), 2.11 (1.73–2.58), and 2.50 (1.86–3.38). Maternal overweight and obesity increased the risk of EOS by group B Streptococcus, Staphylococcus aureus, and Escherichia coli. Half of the association was mediated through preeclampsia, cesarean section delivery, and preterm delivery. A dose-response association was consistently apparent in term infants only. In sibling-controlled analyses, every kilogram per meter squared interpregnancy BMI change was associated with a mean 8.3% increase in EOS risk (95% CI, 1.7%–15.3%; P = .01). Conclusions Risk of EOS increases with maternal overweight and obesity severity, particularly in term infants.

EFFECT OF PASTEURISATION ON THE CONCENTRATIONS OF VITAMIN D COMPOUNDS IN DONOR BREAST MILK

2016 ◽  
Vol 101 (9) ◽  
pp. e2.19-e2 ◽  
Author(s):  
Fabio Gomes ◽  
Nick Shaw ◽  
Karen Whitfield ◽  
Pieter Koorts ◽  
Helen McConachy ◽  
...  
Keyword(s):  
Vitamin D ◽  
Breast Milk ◽  
Preterm Infants ◽  
Rank Test ◽  
Milk Samples ◽  
Vitamin D Analogues ◽  
Lactating Mothers ◽  
Signed Rank ◽  
Liquid Chromatography Tandem Mass ◽  
Signed Rank Test

AimBreastmilk is considered the most important nutrient and source of supplementation for both term and preterm infants.1 It is composed of many important nutrients, including vitamin D.2 The content of this vitamin in breast milk is usually low, even for lactating mothers with adequate vitamin D status.2 3 Preterm infants are at the great risk of vitamin D deficiency due to decreased transplacental transfer.4 Premature infants are the main recipients of pasteurised donor human milk (PDHM), when their mothers are unable to provide their own.This study aims to evaluate the effect of pasteurisation on the concentrations of vitamin D compounds in donor breast milk.MethodA total of 16 participants, who donated breast milk to the RBWH milk bank, were recruited in this study. Milk samples were obtained pre- and post-Holder pasteurisation. Liquid chromatography tandem mass spectrometry (LC-MS/MS) was used to analyse the samples for vitamins D2 and D3 and 25-hydroxyvitamins D2 and D3 (25(OH)D2 and 25(OH)D3). The significance of differences in vitamin D concentrations between the two groups of milk samples was assessed using the Wilcoxon matched-pairs signed rank test, in which P<0.05 was considered significant.ResultsPasteurisation resulted in a significant reduction (P<0.05) in the content of D2, D3, 25(OH)D2 and 25(OH)D3, with P values of 0.0001 for all targeted analytes. The concentrations of the vitamin D analogues in non-pasteurised milk ranged from 3.6 to 5.0 pM (D2), 1.0 to 9.8 pM (D3), 1.4 to 2.1 pM (25(OH)D2) and 1.2 to 9.3 pM (25(OH)D3). The concentrations of the vitamin D analogues in post-pasteurised milk ranged from 3.0 to 4.0 pM (D2), 0.6 to 9.5 pM (D3), 1.2 to 1.7 pM (25(OH)D2) and 1.1 to 9.1 pM (25(OH)D3). Losses of vitamin D compounds resulting from the pasteurisation process ranged from 10% to 20%.ConclusionPasteurisation significantly affected the concentration of vitamin D compounds in pasteurised donor breast milk.

Breast Milk and Breastfeeding of Infants Born to SARS-CoV-2 Positive Mothers: A Prospective Observational Cohort Study

2021 ◽  
Author(s):  
Bgee Kunjumon ◽  
Elena V. Wachtel ◽  
Rishi Lumba ◽  
Michelle Quan ◽  
Juan Remon ◽  
...  
Keyword(s):  
Cohort Study ◽  
Breast Milk ◽  
World Health ◽  
Nasopharyngeal Swab ◽  
Published Data ◽  
New York University ◽  
Positive Screen ◽  
Milk Samples ◽  
Lactating Mothers

Objective There are limited published data on the transmission of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus from mothers to newborns through breastfeeding or from breast milk. The World Health Organization released guidelines encouraging mothers with suspected or confirmed COVID-19 to breastfeed as the benefits of breastfeeding outweighs the possible risk of transmission. The objective of this study was to determine if SARS-CoV-2 was present in the breast milk of lactating mothers who had a positive SARS-CoV-2 nasopharyngeal swab test prior to delivery, and the clinical outcomes for their newborns. Study Design This was a single-center, observational, prospective cohort study. Maternal–newborn dyads that delivered at New York University Langone Hospital Brooklyn with confirmed maternal SARS-CoV-2 positive screen test at the time of admission were recruited for the study. Breast milk samples were collected during postpartum hospitalization and tested for the presence of SARS-CoV-2 genes N1 and N2 by two-step reverse transcription polymerase chain reaction. Additionally, the clinical characteristics of the maternal newborn dyad, results of nasopharyngeal SARS-CoV-2 testing, and neonatal follow-up data were collected. Results A total of 19 mothers were included in the study and their infants who were all fed breast milk. Breast milk samples from 18 mothers tested negative for SARS-CoV-2, and 1 was positive for SARS-CoV-2 RNA. The infant who ingested the breast milk that tested positive had a negative nasopharyngeal test for SARS-CoV-2, and had a benign clinical course. There was no evidence of significant clinical infection during the hospital stay or from outpatient neonatal follow-up data for all the infants included in this study. Conclusion In a small cohort of SARS-CoV-2 positive lactating mothers giving birth at our institution, most of their breast milk samples (95%) contained no detectable virus, and there was no evidence of COVID-19 infection in their breast milk-fed neonates. Key Points

Fluoride levels in breast milk and infant foods

2000 ◽  
Vol 24 (4) ◽  
pp. 299-302 ◽  
Author(s):  
Ece Koparal ◽  
Fahinur Ertugrul ◽  
Kemal Oztekin
Keyword(s):  
Breast Milk ◽  
Cow’S Milk ◽  
Fluoride Level ◽  
Cow's Milk ◽  
Infant Foods ◽  
Milk Samples ◽  
Fluoride Intake ◽  
Lactating Mothers ◽  
Fluoride Electrode ◽  
Very High

The aim of the present study is to determine the fluoride concentrations of breast milk, several milk formulations, cow's milk and yogurt shake in a nonfluoridated area, in order to estimate the fluoride intake of infants and evaluate fluoride supplementation suggestions. Breast milk samples were collected from 57 lactating mothers. Ten brands of milk formulations, 9 different brands of cow's milk and 3 brands of yogurt shake were purchased from the market. Fluoride concentrations of the samples were analyzed using a specific fluoride electrode. The average fluoride level was 0.019±0.004 ppm in breast milk, 0.022±0.007 ppm in cow's milk and 0.022±0.003ppm in yogurt shake. Fluoride levels of milk formulations prepared by distilled water were ranging between 0.118 to 0.021 ppm. It is concluded that in non-fluoridated areas, fluoride intake of infants from the above sources is not very high and fluoride supplements may be prescribed.

scholarly journals Assessment of Aflatoxin M1 in human breast milk in Rafsanjan, Iran

2021 ◽  
Author(s):  
Somayeh Pourtalebi ◽  
Seyyed Amin Ayatollahi Mousavi ◽  
Zahra Assadollahi ◽  
Seyyed Mahdi Mousavi
Keyword(s):  
Breast Milk ◽  
Cross Sectional Study ◽  
Aflatoxin M1 ◽  
Enzyme Linked Immunosorbent Assay ◽  
Human Breast Milk ◽  
The European Union ◽  
Postnatal Exposure ◽  
Cross Sectional ◽  
Milk Samples ◽  
Lactating Mothers

Background and Purpose: Aflatoxins (AFs) are a group of highly toxic mycotoxins present both in the environment and in foodstuffs. The food of infants should be safe and free of various pollutants, including breast milk mycotoxins. This study aimed to measure the mycotoxin of Aflatoxin M1 (AFM1) in human milk samples obtained from lactating mothers living in Rafsanjan city, Iran.  Materials and Methods: In the current cross-sectional study, breast milk samples were collected from 150 lactating mothers in Rafsanjan city from September 2015 to April 2016 using the structured food-frequency questionnaire. The AFM1 was measured by employing enzyme-linked immunosorbent assay specific kits. The statistical analysis was performed in SPSS software (version 16). Results: The AFM1 was detected in 98 mothers (65%) with a mean concentration of 14.69±8.15 ng/kg, ranging from 5.02 to 41.25 ng/kg. The AFM1 concentration exceeded the tolerable and accepted limit promulgated by the European Union and the USA (25 ng/kg) in only 10 milk samples. Moreover, in 59 milk samples, the AFM1 concentration exceeded the limit recommended by Australia and Switzerland (10 ng/kg). Conclusion: According to the results of the present study, lactating mothers and their infants are at risk of AFM1 exposure in southern Iran. Accordingly, the examination of AFM1 concentrations in lactating mothers, as a critical postnatal exposure marker of infants to this carcinogenic compound, requires further studies in various seasonal periods and different parts of Iran.

Sign in / Sign up

Export Citation Format

Share Document